SMARCA1 and prostate adenocarcinoma: SWI/SNF chromatin remodeling complexes interact with different lineage-specific factors in NEPC compared to prostate adenocarcinoma, pointing to a role for SWI/SNF complexes in therapy-related lineage plasticity [54].